Article: Paxil(R) Shows Effectiveness With Fewer Side Effects In Treating Depressed Patients With Ischemic Heart Disease

Study Presented at APA Meeting Compares Paroxetine and Nortriptyline

SAN DIEGO, May 21 /PRNewswire/ -- The antidepressant paroxetine HCl (Paxil, SmithKline Beecham) demonstrated effectiveness and was associated with fewer side effects than nortriptyline in the treatment of depressed patients with ischemic heart disease, researchers reported today at the annual meeting of the American Psychiatry Association.(A)

"The need to find a safe and effective treatment for depressed patients with ischemic heart disease is critical because depression following myocardial infarction increases risk for mortality," said Steven Roose, M.D., professor of clinical ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!